Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions

Peripheral Arterial Disease

Interventions

DRUG

XRP0038 (NV1FGF)

Trial Locations (6)

Ghent University Hospital, Ghent

Hôpital Européen Georges Pompidou, Paris

Klinikum Karlsbad-Langensteinbach, Karlsbad

Istituto Dermopatico dell'Immacolata, Roma

Universitätsklinik, Bern

St George's Hospital, London